CN108486119A - A kind of aptamer RhB-F02 and its application with rhodamine B specific binding - Google Patents
A kind of aptamer RhB-F02 and its application with rhodamine B specific binding Download PDFInfo
- Publication number
- CN108486119A CN108486119A CN201810178606.2A CN201810178606A CN108486119A CN 108486119 A CN108486119 A CN 108486119A CN 201810178606 A CN201810178606 A CN 201810178606A CN 108486119 A CN108486119 A CN 108486119A
- Authority
- CN
- China
- Prior art keywords
- aptamer
- rhodamine
- rhb
- hole
- incubated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 102
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 title claims abstract description 74
- 229940043267 rhodamine b Drugs 0.000 title claims abstract description 72
- 230000009870 specific binding Effects 0.000 title claims description 12
- 238000001514 detection method Methods 0.000 claims abstract description 15
- 239000002773 nucleotide Substances 0.000 claims abstract description 10
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 108020004414 DNA Proteins 0.000 abstract description 23
- 102000053602 DNA Human genes 0.000 abstract description 13
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 238000012216 screening Methods 0.000 abstract description 8
- 108020004682 Single-Stranded DNA Proteins 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 6
- 108091034117 Oligonucleotide Proteins 0.000 abstract description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract description 4
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 238000010494 dissociation reaction Methods 0.000 abstract description 2
- 230000005593 dissociations Effects 0.000 abstract description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 44
- 239000007788 liquid Substances 0.000 description 35
- 239000000243 solution Substances 0.000 description 26
- 238000005406 washing Methods 0.000 description 25
- 238000000034 method Methods 0.000 description 23
- 229960002685 biotin Drugs 0.000 description 22
- 235000020958 biotin Nutrition 0.000 description 22
- 239000011616 biotin Substances 0.000 description 22
- 239000000853 adhesive Substances 0.000 description 21
- 230000001070 adhesive effect Effects 0.000 description 21
- 241001349468 Elona Species 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 11
- 210000004080 milk Anatomy 0.000 description 11
- 235000013336 milk Nutrition 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 240000004160 Capsicum annuum Species 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 7
- 238000002372 labelling Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 230000010355 oscillation Effects 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 235000015067 sauces Nutrition 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 238000002983 circular dichroism Methods 0.000 description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 229920000877 Melamine resin Polymers 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 2
- 108091008104 nucleic acid aptamers Proteins 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GUYIZQZWDFCUTA-UHFFFAOYSA-N (pentadecachlorophthalocyaninato(2-))-copper Chemical compound [Cu+2].N1=C([N-]2)C3=C(Cl)C(Cl)=C(Cl)C(Cl)=C3C2=NC(C2=C(Cl)C(Cl)=C(Cl)C(Cl)=C22)=NC2=NC(C2=C(Cl)C(Cl)=C(Cl)C(Cl)=C22)=NC2=NC2=C(C(Cl)=C(C(Cl)=C3)Cl)C3=C1[N-]2 GUYIZQZWDFCUTA-UHFFFAOYSA-N 0.000 description 1
- XGIKILRODBEJIL-UHFFFAOYSA-N 1-(ethylamino)ethanol Chemical compound CCNC(C)O XGIKILRODBEJIL-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012916 chromogenic reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000002117 illicit drug Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000005315 stained glass Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of aptamer RhB F02 for obtaining specifically binding with rhodamine B using SELEX technology screenings, and the aptamer is single stranded DNA, is made of 82 nucleotide, nucleotide sequence such as SEQ ID NO:Shown in 1;Its secondary structure contains ring and stem outstanding, and there are tetra- stranded structures of G, wherein RhB F02 Gibbs free energies DG=10.97.The a series of properties assessment such as aptamer specificity, affinity and sensitivity is carried out based on enzyme-linked oligonucleotides adsorption measurement, shows RhB F02 dissociation constantsK d =20.89 ± 2.37 nM, and specific can be combined with rhodamine B, therefore the aptamer has the characteristics that high specific, high-affinity, can enzyme rapidly and sensitively be used for the detection of rhodamine B.
Description
Technical field
The present invention relates to a kind of aptamer with rhodamine B specific binding and its applications, belong to biomedical skill
Art field.
Background technology
Aptamer is by index concentration Fas lignand system evolution technology (SyStematic evolution of
LigandS by exponential enrichment, SELEX) screening obtains can be with metal ion, small molecule, big point of biology
Son, or even entire cell high specific and the ssDNA or RNA of high-affinity combination.Aptamer not only has antibody molecule
Specific recognition, every diagnostic field for being related to antibody can nearly all replace with aptamer, and be also equipped with from
The unique excellent properties of body, with target molecule range is wide, molecular mass is small, immunogenicity is low, be easy to chemical synthesis, transformation and
The advantages that label.In recent years, aptamer is in treatment new drug, medicament transport, cancer cell detection, bio-imaging, biological marker
There is application in the biomedical sectors such as the discovery of object, illicit drugs inspection, antiviral.
Rhodamine B (Rhodamine B) is also known as rose red b or basic rhodamine, and it is red to be commonly called as pollen, is a kind of to have fresh peach
Red artificial synthesized dyestuff.Rhodamine B has strong fluorescence in the solution, is typically used as the cell fluorescence in laboratory and contaminates
The industries such as toner, coloured glass, characteristic fireworks and firecrackers.But since rhodamine B has cheap, the red gorgeous, stability of color and luster
The features such as strong, many illegal businessmans are in order to seek exorbitant profit, by the colorant in its substitute food product additive, addition in chilli powder and
In the foods such as chilli oil, the purpose is to keep food beautiful, but largely addition rhodamine B can bring pole to the safe diet of people
Big hidden danger.According to investigations, rhodamine B can make intake, sucking and skin contact person generate a series of malaise symptoms, such as dizzy,
Vomiting, abdominal pain, leucocyte such as increase at the symptoms, in turn result in acute or chronic middle toxicity damage.Related data shows, rhodamine B
Protein staining can be also destroyed, many experiments have also further demonstrated that rhodamine B can cause mouse subcutaneous tissue to generate sarcoma, and
With potential carcinogenic and teratogenesis.
Currently, the method for detection rhodamine B mainly has two kinds of high performance liquid chromatography and efficient liquid phase tandem mass spectrometry.But
It is that both detection methods are required for specific instrument and equipment, preferable professional knowledge and certain operative skill, it can not be extensive
Using.In order to ensure the health of broad masses of the people, illegal retailer is hit, is established a kind of accurate and reliable, sensitive quick, wide
The method of general applicable detection rhodamine B is particularly important in food security work.
Invention content
The object of the present invention is to provide a kind of aptamer RhB-F02 with rhodamine B specific binding, nucleotide
Sequence such as SEQ ID NO:Shown in 1;The aptamer is single stranded DNA, is made of 82 nucleotide, topology is straight chain
Shape;The secondary structure of prediction has ring outstanding and stem, and there are tetra- stranded structures of G-, Gibbs free energy DG=- 10.97.
The present invention is making another object is that the above-mentioned aptamer RhB-F02 with rhodamine B specific binding is applied
It is standby to detect the reagent of rhodamine B in food or detected in food in the kit of rhodamine B preparing.
It is a series of with specificity, affinity and the sensitivity of aptamer RhB-F02 of rhodamine B specific binding etc.
Property assessment is based primarily upon enzyme-linked oligonucleotides adsorption measurement(ELONA).
The present invention is achieved by the following scheme goal of the invention:
1, the screening of rhodamine B specific nucleic acid aptamers, clone, separation and sequencing
Go out the aptamer group that can be specifically bound with rhodamine B using SELEX technology screenings, design primer carries out
PCR amplification, clone, separation and sequencing;Utilize enzyme-linked oligonucleotides adsorption experiment(ELONA)It is verified, obtains aptamers
RhB-F02, it is capable of the combination rhodamine B of high-affinity high specific;Ligand adapter-primer sequence is:Aptamer Fw:
GACATATTCAGTCTGACAGC;Reverse complementary sequence:CGCTGTCAGACTGAATATGTC;Aptamer Rv:
GCTAGACGATATTCGTCCATC, reverse complementary sequence:GATGGACGAATATCGTCTAGC;Obtained positive monoclonal carries out core
Nucleotide sequence measures, and sequencing result shows that the aptamer specifically bound with rhodamine B is made of 82 nucleotide, sequence
Row(5 ' ends to 3 ' ends)For:
GCTAGACGATATTCGTCCATCTCCCGTGCATCCGAGACCGTGAGTTGGACTGACCCGCTTCCGCTGTCAGACT
GAATATGTC。
2, aptamer single stranded DNA secondary structure characterizes
Use MFOLD softwares(http://mfold.rna.albany.edu/q=mfold/DNA-Folding-Form)Pair and sieve
The aptamer RhB-F02 single strand dnas of red bright B specific bindings carry out secondary structure prediction.The result shows that two level
Structure has ring outstanding and stem, and there are tetra- stranded structures of G-, it is higher that Gibbs free energy DG=- 10.97 shows that the structure has
Stability;Its secondary structure is shown in Fig. 1.
3, the specificity, affinity of aptamer and its sensitivity to rhodamine B
According to the sequence of aptamer RhB-F02, the aptamer marked with in-vitro transcription method synthesizing biotinylated(Nucleic acid
The nucleotide sequence 5 ' of aptamers RhB-F02 is held by biotin labeling), establish a kind of novel enzyme-linked oligonucleotides detection side
Method to the specificity of aptamer, affinity and its is detected the sensitivity of rhodamine B by the method;As a result it shows
Show, RhB-F02 dissociation constantsKd=20.89 ± 2.37 nM, and RhB-F02 has very high specificity, can detect sieve
The minimum concentration of red bright B Wei not 10 ng/mL;
The specific method is as follows:
(1)0.05 M pH, 9.6 carbonate buffer solutions are 1 with rhodamine B volume ratio:1 mixing, final concentration of the 50 of rhodamine B
ng/μL.It is added in ELISA Plate per 100 μ L of hole, is sealed with adhesive sticker, in being incubated 2h on 37 DEG C, 100 rpm/min shaking tables.
Then the liquid in hole is discarded, 200 μ L PBST cleaning solutions are added per hole, in oscillation washing 3 times on horizontal constant-temperature table, every time
It is patted dry on clean blotting paper after washing 2 min.
(2)100 μ L, 5% defatted milks are added per hole to be closed, is sealed with adhesive sticker, is shaken in 37 DEG C, 100 rpm/min
It is incubated 2h on bed.Liquid in hole is discarded, is then repeated(1)In washing step.
(3)It is molten that the aptamer RhB-F02 for indicating biotin is dissolved into a concentration of 100 μM of storage with aqua sterilisa
Liquid, then it is diluted to 1 × PBS the working concentration of 100 nM.Per hole be added 100 μ L, sealed with adhesive sticker, in 37 DEG C, 100
2 h are incubated on rpm/min shaking tables.Liquid in hole is discarded, is then repeated(1)In washing step.
(4)The horseradish peroxidase conjugate that 100 μ L indicate Streptavidin is added per hole(Stretavidin-
HRP), sealed with adhesive sticker, in being incubated 2 h on 37 DEG C, 100 rpm/min shaking tables.Liquid in hole is discarded, is then repeated(1)In
Washing step.
(5)100 μ L TMB chromogenic reagent solutions are added per hole, are sealed with adhesive sticker, 20 min of colour developing are protected from light at 37 DEG C.
(6)50 μ L terminate liquids are added per hole(2 M sulfuric acid), and within 10 min of reaction terminating, use microplate reader
Absorbance value of each hole at 450 nm is detected, OD450 is obtained.
4, the truncation experimental analysis of aptamer
Aptamer RhB-F02 is truncated by ELONA methods to determine best combination site.Based on aptamer
The secondary structure of RhB-F02 predictions(Fig. 1), aptamers RhB-F02 is truncated, the following table of sequence, secondary structure after truncation
As shown in Figure 7;The results show that the segment after truncating cannot identify target molecule, therefore, aptamer RhB-F02 shows that its is complete
Whole three-dimensional structure is capable of the identification target molecule of high-affinity.
;
5, the detection and analysis of food simulation addition rhodamine B
The rhodamine B standard items that four different levels are added in thick chilli sauce sample, are handled, and built with this using identical method
Found the rate of recovery of this detection method;Aptamer RhB-F02 is 81.67% ~ 97.51% to the rhodamine B rate of recovery, therefore is utilized
The ELONA methods that aptamers RhB-F02 is set up may be used as the actually detected of rhodamine B in food, can be used for subsequently examining
The preparation of test agent box.
Meaning of the present invention is:
It is capable of the identification of high-affinity high specific using the aptamer RhB-F02 that SELEX technology screenings go out and combines sieve
It is red bright;Detection of the discriminating of aptamer RhB-F02 for remaining rhodamine B in food, and then rhodamine B is reduced to people
The infringement of body is of great significance.
Description of the drawings
Fig. 1 is the secondary structure schematic diagram of aptamer RhB-F02;
Fig. 2 is CD circular dichroism detectors in the present invention to K+The analysis result of concentration and the relationship of aptamer RhB-F02;
Fig. 3 is that ELONA methods analyze the specificity of aptamer RhB-F02 in the present invention, in figure:Blank control CK1:Degreasing
Milk;Blank control CK2:Biotin;Negative control 1-6 is:Non-target substance(Tonyred, melamine, glyphosate, hydrochloric acid gram
Lun Teluo, orthene, Furadan);Positive group:Rhodamine B;
Fig. 4 is that ELONA methods analyze the optium concentration of aptamer RhB-F02 in the present invention, in figure:Blank control CK1:It is de-
Fat milk;Blank control CK2:Biotin;Positive group:It is marked with the aptamers RhB-F02 of biotin;
Fig. 5 is ELONA methods in the present invention to the affinity analysis of aptamer RhB-F02, aptamer RhB-F02 and sieve
The affinity of the combination of red bright B is usedK d Value indicates;
Fig. 6 is analysis of the ELONA methods to rhodamine sensitivity in the present invention, in figure:Blank control CK1:Defatted milk;Blank control
CK2:Biotin;Positive group:It is marked with the aptamers RhB-F02 of biotin;
Fig. 7 is the secondary structure figure of the aptamer RhB-F02 after different loci truncates;
Fig. 8 is truncation experimental analysis of the ELONA methods to aptamer RhB-F02 in the present invention, in figure:Blank control CK1:It is de-
Fat milk;Blank control CK2:Biotin;Positive group:It is marked with the aptamers RhB-F02 of biotin and is marked with cutting for biotin
Short aptamers F1575, F2054, F3454.
Specific implementation mode
With reference to the accompanying drawings and examples come the essentiality content further illustrated the present invention, embodiment is only for more preferably managing
The solution present invention but do not limit to and the scope of the invention, method is conventional method, the reagent used unless otherwise specified in embodiment
The reagent for being conventional commercial reagent unless otherwise specified or preparing according to a conventional method.
Embodiment 1:The screening of rhodamine B aptamer
One, aglucon(Rhodamine B)With matrix(Ago-Gel 6B)Coupling
1, in sintered glass filter(More reciprocal of duty cycle G3)With the freeze-dried powder Ago-Gel 6B for 1 g that suspends in 3 mL distilled water;
2, immediately in sintered glass filter with the coupling buffer solution of 200 mL(The carbonate buffer solution of 0.05 M, pH 9.6)
1 h of washing matrix;
3, the aglucon that 6 g are dissolved with the coupling buffer solution of 6 mL, it is 1 mg/mL to make its ultimate density;
4, a concentration of 1 mg/mL in step 2 matrix and step 3 buffer solution of aglucon by volume 1 has been dissolved into:2 ratios
Mixing handles 16 h, and 37 DEG C of incubator overnights under 35 DEG C -40 DEG C of water bath condition;
5, under conditions of 40 DEG C -50 DEG C, with the superfluous group of the ethylaminoethanol closing of 1M, at least 4 h or overnight;
6, surplus aglucon is washed with coupling buffer, 4000 rpm centrifuge 2 min, draw supernatant;Use ultra-pure water(Each 7-8
mL)Cleaning 3 times;And then it uses and contains 0.1 M NaHCO3, 0.5 M NaCl pH 8.0 solution clean 3-4 times;Then it uses
Solution containing 0.1 M NaCl, the pH 4.0 of 0.1 M acetate cleans 3-4 times;It is 20% second finally to use mass percent concentration
6 mL of alcohol is preserved, and is positioned over 4 DEG C of refrigerators, and sealed membrane sealing is vertical to place.
Two, aptamer library(ssDNA)PCR
The ssDNA aptamers library synthesized using TaKaRa companies;
1,94 DEG C of preheating PCR instruments;
2, by 3 μ L ssDNA, 30.6 μ L deionized waters, 5 μ L10 × Buffer, 3 μ LMgCl2, 4 μ L dNTP mixtures
(Each 2.5 μM), 2 μ L forward directions amplimers, the reversed amplimers of 2 μ L and 0.4 μ L Taq enzyme centrifuge tubes reacted;Just
It is 5 '-GACATATTCAGTCTGACAGC-3 ' to amplimer sequence, reversed amplimer sequence is 5 '-
GCTAGACGATATTCGTCCATC-3’。
3, it is expanded by following procedure in PCR instrument
(1) pre-degeneration
94 ℃ 5 min;
(2) 40 cycles
94 ℃ 45 s
58 ℃ 45 s
72 ℃ 30 s;
(3) it expands afterwards
72 ℃ 7 min。
Three, the purifying in ligand library, loading and elution
1, the purifying in ligand library
(1) aptamer library PCR product directly with the solution in plastic recovery kit by volume 1:1 ratio mixes, into
Row DNA fragmentation recycles;
(2) after DNA fragmentation recycling, 95 DEG C of 10 min of water-bath, 10 min of ice bath;By this denaturation treatment, double-stranded DNA is made to become
Single stranded DNA.
2, affinity chromatography
(1) matrix being coupled is eluted with coupling buffer:Upper solution is drawn, adds coupling buffer to 6 mL, mixing, from
The heart discards supernatant liquid, this step is repeated 3 times;
(2) single stranded DNA in step 1 is added in the matrix being coupled, is incubated in 37 DEG C and 40 rpm softly rotates 2 h;
(3) it is added in aforementioned sample to chromatographic column, with the ultrapure water pillar of 2-3 column volumes;
(4) and then with the elution buffers of 3-4 column volumes(0.1 M NaCl, 0.1 M acetate, pH 4.0)Carry out linear gradient
Elution fraction is collected in elution;
(5) elution fraction mixes in equal volume with sol solution, is dissolved with TE solution after recycling, obtains Selex solution.
Four, PCR optimizations and large amplification aptamer
Using above-mentioned Selex solution as template, operate as follows:
1,94 DEG C of preheating PCR instruments;
2, by 5 μ L templates, 28.6 μ L deionized waters, 5 μ L10 × Buffer, 3 μ LMgCl2, 4 μ L dNTP mixtures(Respectively
2.5 μM), 2 μ L forward directions amplimers, the reversed amplimers of 2 μ L, 0.4 μ LTaq enzymes, reacted in PCR centrifuge tubes.
Positive amplimer sequence is 5 '-GACATATTCAGTCTGACAGC-3 ', and reversed amplimer sequence is 5 '-
GCTAGACGATATTCGTCCATC-3’。
3, it is expanded by following procedure in PCR instrument:
(1) pre-degeneration
94 ℃ 5 min;
(2) 37 cycles:
94 ℃ 45 s
58 ℃ 45 s
72 ℃ 30 s;
(3) it expands afterwards
72 ℃ 7 min;
4, after circulation terminates, PCR products are stripped recycling, step with the DNA product purification kit of TIANGEN companies
It is as follows:
(1) PCR product with isometric film is combined buffering overturn mixing, mixed liquor is then transferred to centrifugal purification column, room temperature
5 min are stood, DNA is made fully to be combined with pellosil, 12000 rpm centrifuge 1 min, outwell the waste liquid in collecting pipe;
(2) rinsing liquid of 700 μ L is added(Containing ethyl alcohol)In centrifugal purification column, 12000 rpm centrifuge 1 min, outwell collection
Waste liquid in pipe;
(3) step is repeated(2);
(4) 12000 rpm centrifuge 3 min;
(5) centrifugal purification column is placed in new centrifuge tube;
(6) 30 μ L ultra-pure waters are added, stand 5 min at room temperature;
(7) 12000 rpm centrifuge 1 min, and tube bottom solution is the PCR product of the aptamer purified.
Embodiment 2:The clone of aptamer, separation and sequencing and the prediction of single stranded DNA secondary structure
One, the preparation of bacillus coli DH 5 alpha competent cell
1, the single DH5 α bacterium colonies of picking are inoculated in LB culture mediums of 3 mL without ampicillin, and 37 DEG C of overnight incubations are secondary
Day takes above-mentioned bacterium solution in proportion 1:100 are inoculated in 50 mL LB liquid mediums, 37 DEG C of 2 min of oscillation;When OD600 values reach
When to 0.35, bacterial cultures is harvested;
2, bacterial cultures is transferred in the sterile polypropylene tube of 50 mL precoolings, places 10 min on ice, makes culture
It is cooling;
3,4000 rpm centrifuge 10 min at 4 DEG C, discard culture solution, and pipe is inverted l min so that remaining culture liquid stream
To the greatest extent;
4, respectively add 0.1 mM CaCl of 150 μ L ice precooling2Solution merges two pipes, 10 min of ice bath;
5,4000 rpm centrifuge 10 min at 4 DEG C, discard supernatant liquid, and pipe is inverted l min so that residual liquid stream
To the greatest extent;
6,0.1 M CaCl of 800 μ L ice precooling are first added2Cell is resuspended in solution, adds 75% glycerine of 25 μ L precoolings,
It is spare in -80 DEG C of storages later.
Two, connection and the conversion of connection product
1,0.5 μ L Takara pMD19-T Simple carriers, 4.5 μ L aptamers PCR are added in microcentrifugal tube
The ligase buffer mixture of product and 5 μ L;
2,16 DEG C of 3 min of reaction;
3, full dose(10 μL)It is added into 100 μ L DH5 α competent cells, 30 min is placed in ice;
4, after 42 DEG C of 90 s of heating, then 1 min is placed in ice;
5, LB culture mediums 890 μ L, 37 DEG C of 60 min of slowly vibrating culture that 37 DEG C of warm bath are crossed is added;
6, take 200 μ L be coated on containing X-Gal, IPTG, ampicillin LB culture mediums on, 37 DEG C culture 16 min with shape
At single bacterium colony.
Three, the colony screening of aptamer, separation and sequencing and single stranded DNA secondary structure prediction
The single bacterium of the above-mentioned white of picking is fallen in the LB culture mediums containing ampicillin, 37 DEG C of 4 min of slowly vibrating culture, into
Row PCR amplification;The amplification condition of amplimer and amplification condition with aforementioned aptamer.The positive colony that will be confirmed through PCR
After carrying out plasmid extraction, nucleotide is carried out with the full-automatic nucleotide sequencing instrument of U.S. Applied BioSyStemS3730A
The measurement of sequence;Structure shows that its sequence of the aptamer specifically bound with rhodamine B is from 5 ' ends to 3 ' ends:
GCTAGACGATATTCGTCCATCTCCCGTGCATCCGAGACCGTGAGTTGGACTGACCCGCTTCCGCTGTCAGACT
GAATATGTC;
With the sequence length of the aptamer RhB-F02 of rhodamine B specific binding:82 bases, sequence type:Nucleic acid,
Chain number:It is single-stranded, topology:Straight-chain, sequence type:ssDNA.
It is 26 DEG C, Na that temperature, which is arranged, by MFOLD softwares+A concentration of 150 mM, Mg2+A concentration of 1 mM(http://
mfold.rna.albany.edu/q=mfold/DNA-Folding-Form)It is mapped with QGRS(http://
bioinformaticS.ramapo.edu/QGRS/analyze.php)Pair with rhodamine B specific binding aptamer
RhB-F02 single strand dnas carry out secondary structure prediction.The result shows that aptamers contain ring and stem outstanding, RhB-F02 is lucky
Buss free energy DG=- 10.97;Structure has higher stability(See Fig. 1).
Embodiment 3:Circular dichroism detector is to K+Concentration is probed into the relationship of aptamer RhB-F02
1, after aptamers being diluted to 20 μM with aqua sterilisa, 0.5 min is denaturalized in 94 DEG C with the speed of 0.5 DEG C/min
It is cooled to 25 DEG C;
2, aptamer RhB-F02 is diluted to the KCl solution of various concentration (0,10,20,40,60,80,100 mM)
2.5 μM;
3, it is detected with circular dichroism spectrometer at 25 DEG C, 220-340 nm wavelength(As a result see Fig. 2).
The result shows that:Chromatography has negative peak between 240 ~ 250 nm, has posivtive spike between 275 ~ 285 nm.Because
240 ~ 250 peaks nm are the characteristic peaks of tetra- serobilas of G-, and 275 ~ 285 peaks nm are stem ring characteristic peaks, so aptamer RhB-F02
It can be stabilized in KCl solution and not interfere with its secondary structure.
Embodiment 4:Specificity, affinity and the sensitivity to rhodamine B of aptamer RhB-F02
One, aptamer RhB-F02 specific detections
1, ELONA methods
It is improved on the basis of traditional ELISA method, antibody is replaced with the aptamers screened, using biology
Element-Avidin amplification system is detecting sample to be tested.
(1) coating of toxin
9.6 carbonate buffer solutions of 0.05M pH are 1 with rhodamine B volume ratio:1 mixing, the final concentration of 50 ng/ μ of rhodamine B
L.It is added in ELISA Plate per 100 μ L of hole, is sealed with adhesive sticker, in being incubated 2 h on 37 DEG C, 100 rpm oscillators, be incubated
The liquid in hole is discarded afterwards, 200 μ L PBST cleaning solutions are added per hole, in oscillation washing 3 times on horizontal constant-temperature table, is washed every time
It is patted dry on clean blotting paper after washing 2 min.Set up blank control and negative control (blank control 1 simultaneously:Defatted milk;It is empty
White control 2:Biotin;Negative control 1-6 is:Non-target substance(Tonyred, melamine, glyphosate, clenobuterol hydrochloride,
Orthene, Furadan, concentration are consistent, and method is same as above).
(2) it closes
In the ELISA Plate for being coated with rhodamine B toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker, it
Afterwards, in being incubated 2 h on 37 DEG C, 100 rpm oscillators, after closing, liquid in hole is discarded, repeats step(1)In washing
Step.
(3) plus the aptamer with biotin labeling is incubated
Screening obtains that the conjunction of Shanghai Sheng Gong biotech firms can be sent to the aptamer RhB-F02 that rhodamine B toxin is combined
At biotin is used in combination(Biotin)Mark RhB-F02.In use, first carrying out of short duration centrifugation, make the nucleic acid of labeled biotin
Aptamers are all gathered in test tube bottom.It is with aqua sterilisa that the aptamer of labeled biotin is fully molten according to explanation
Solution is at a concentration of 10-4 The storing solution of M can be packed as aliquot in order to avoid freeze thawing repeatedly.
The aptamer RhB-F02 of labeled biotin is diluted to the working concentration of 100 nM with 1 × PBS, then,
100 μ L are added in each hole, after adhesive sticker or sealed membrane sealing, in being incubated 2 h on 37 DEG C, 100 rpm oscillators, are incubated it
Afterwards, liquid in hole is discarded, step is repeated(1)In washing step.
(4) enzyme conjugate is incubated
It 100 μ L is added in each hole indicates the horseradish peroxidase conjugate of Streptavidin and then sealed with adhesive sticker,
Later, in being incubated 1 h on 37 DEG C, 100 rpm oscillators, after incubation, liquid in hole is discarded, repeats step(1)In washing
Step.
(5) it develops the color
100 μ L of color developing agent TMB solution are added in per hole, are protected from light 20 min of colour developing at 37 DEG C later.
(6) it terminates
Finally, the terminate liquid (2 M sulfuric acid) of 50 μ L is added into per hole, and to be used within 10 min of reaction terminating
Microplate reader detects absorbance value of each hole at 450 nm, obtains OD450.
The results show that aptamers RhB-F02 can and rhodamine B specificity combination(As a result see Fig. 3).
Two, the detection of aptamer RhB-F02 optimal uses concentration
1,9.6 carbonate buffer solutions of 0.05M pH and rhodamine B volume ratio are 1:1 mixing, final concentration of the 50 of rhodamine B
ng/μL.It is added in ELISA Plate per 100 μ L of hole, is sealed with adhesive sticker, in being incubated 2 h on 37 DEG C, 150 rpm oscillators, incubated
Liquid in hole is discarded after having educated, and adds 200 μ L of cleaning solution per hole, in oscillation washing 3 times on horizontal shaker, 2 min every time, equally
To be patted dry on clean blotting paper every time;
2, in the ELISA Plate for being coated with rhodamine B toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker,
Later, in being incubated 2h on 37 DEG C, 100 rpm oscillators, after closing, liquid in hole is discarded, repeats the washing in step 1
Step;
3, by the aptamers of biotin labeling with 1 × PBS be diluted to 1 nM, 10 nM, 40 nM, 80 nM, 100 nM, 250 nM,
500 nM、1000 nM;Each hole adds 100 μ L, is sealed with adhesive sticker or sealed membrane, is incubated on 37 DEG C, 100 rpm oscillators
2 h are educated, liquid in hole is discarded after being incubated, repeat the washing step in step 1;
3,100 μ L horseradish peroxidase conjugates are added in every hole, are sealed with adhesive sticker, in 37 DEG C, 150 rpm oscillators
1 h of upper incubation discards liquid in hole, repeats the washing step in step 1;
4,100 μ L of TMB color developing agents are added per hole, 20 min of colour developing are protected from light in 37 DEG C;
5, add 50 μ L terminate liquids(2 M sulfuric acid), and within 10 min of reaction terminating extinction at each 450 nm of hole is surveyed with microplate reader
Angle value OD450;
The result shows that the optimal use concentration of aptamers RhB-F02 is 80 nM(Fig. 4).
Three, the affinity of aptamer RhB-F02K d Value calculates
1,9.6 carbonate buffer solutions of 0.05M pH and rhodamine B volume ratio are 1:1 mixing, final concentration of the 50 of rhodamine B
ng/μL.It is added in ELISA Plate per 100 μ L of hole, is sealed with adhesive sticker, in being incubated 2 h on 37 DEG C, 150 rpm oscillators, incubated
Liquid in hole is discarded after having educated, and adds 200 μ L of cleaning solution per hole, in oscillation washing 3 times on horizontal shaker, 2 min every time, equally
To be patted dry on clean blotting paper every time;
2, in the ELISA Plate for being coated with rhodamine B toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker,
Later, in being incubated 2h on 37 DEG C, 100 rpm oscillators, after closing, liquid in hole is discarded, repeats the washing in step 1
Step;
3, the aptamers of biotin labeling are diluted to 1 nM, 5nM, 10 nM, 20 nM, 40 nM, 80 nM, 100 with 1 × PBS
NM, each hole add 100 μ L, are sealed with adhesive sticker or sealed membrane, in being incubated 2 h on 37 DEG C, 100 rpm oscillators, have been incubated
After discard liquid in hole, repeat the washing step in step 1;
4,100 μ L horseradish peroxidase conjugates are added in every hole, are sealed with adhesive sticker, in 37 DEG C, 150 rpm oscillators
1 h of upper incubation discards liquid in hole, repeats the washing step in step 1;
5,100 μ L of TMB color developing agents are added per hole, 20 min of colour developing are protected from light in 37 DEG C;
6, add 50 μ L terminate liquids(2 M sulfuric acid), and within 10 min of reaction terminating extinction at each 450 nm of hole is surveyed with microplate reader
Angle value OD450;
The result shows that aptamer RhB-F02K d =20.89±2.37(Fig. 5).
Four, detections of the aptamer RhB-F02 to rhodamine B sensitivity
1,9.6 carbonate buffer solutions of 0.05M pH and rhodamine B volume ratio are 1:1 mixing makes final concentration of the 0.1 of rhodamine B
Ng/mL, 1 ng/mL, 10 ng/mL, 20 ng/mL, 40 ng/mL, 60 ng/mL.It is added in ELISA Plate, uses per 100 μ L of hole
Adhesive sticker seals, and in being incubated 2h on 37 DEG C, 150 rpm oscillators, liquid in hole is discarded after being incubated, and adds cleaning solution 200 per hole
μ L will similarly be patted dry on clean blotting paper every time in oscillation washing 3 times, each 2min on horizontal shaker;
2, in the ELISA Plate for being coated with rhodamine B toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker,
Later, in being incubated 2h on 37 DEG C, 100 rpm oscillators, after closing, liquid in hole is discarded, repeats the purge step in step 1
Suddenly;
3, the aptamers of biotin labeling are diluted to 80 nM with 1 × PBS, each hole adds 100 μ L, with adhesive sticker or sealed membrane
Sealing discards liquid in hole in being incubated 2h on 37 DEG C, 100rpm oscillators after being incubated, repeat the washing step in step 1;
4,100 μ L horseradish peroxidase conjugates are added in every hole, are sealed with adhesive sticker, in 37 DEG C, 150 rpm oscillators
1 h of upper incubation discards liquid in hole, repeats the washing step in step 1;
5,100 μ L of TMB color developing agents are added per hole, 20 min of colour developing are protected from light in 37 DEG C;
6, add 50 μ L terminate liquids(2 M sulfuric acid), and within 10 min of reaction terminating extinction at each 450 nm of hole is surveyed with microplate reader
Angle value OD450;
The result shows that aptamer RhB-F02 detects that the minimum concentration of rhodamine B Wei not 10ng/mL(Fig. 6).
Embodiment 5:The truncation experimental analysis of aptamer RhB-F02
In order to reduce the cost of nucleic acid aptamers, aptamer RhB-F02 is cut based on its secondary structural features
Short experiment is groped.Sequence after aptamer truncates see the table below, and secondary structure is as shown in Figure 7.After being truncated respectively to three
Aptamer segment and full length fragment carry out ELONA methods and are verified, remaining operation is same as above.
The result shows that:Segment after truncation cannot identify target molecule, and therefore, aptamer RhB-F02 is completely three-dimensional
Structure can identify target molecule to high-affinity(Fig. 8);
。
Embodiment 6:The detection and analysis of food simulation addition rhodamine B
According to the effect of the specific recognition rhodamine B of aptamer RhB-F02, establish a kind of based on aptamer
The detection method of rhodamine B in actual sample.The thick chilli sauce of different supermarket's different brands is extracted as sample, prepares 4 groups of samples,
The totally 3 parts of progress parallel laboratory tests of every group of sample, every part weighs 1 g of thick chilli sauce.4 groups of every gram of samples add 10 ng, 40 ng, 80 successively
The rhodamine B of ng, 100 ng, then every part of sample 10 mL ultra-pure waters of addition, stir evenly, and 12000 rpm centrifuge 10 min,
Supernatant is extracted after standing 5 min;It is dense that the aptamer RhB-F02 of biotin labeling is first diluted to 100 μM of storages with ultra-pure water
Degree, then with 1 × PBS to be diluted to 100 nM working concentrations spare.
Four groups of supernatants carry out 1 with 9.6 carbonate buffer solutions of 0.05M pH respectively:1 volume ratio mixes, then per 100 μ of hole
L is coated in 96 orifice plates, is sealed in 37 DEG C, 100 rpm incubations, 2 h.After being incubated, PBST is washed three times, every time 2 min, and
In being patted dry on blotting paper.Secondly, 100 μ L, 5% defatted milks are added per hole, is sealed in 37 DEG C, 100 rpm, 2 h of incubation, has been incubated
Afterwards, washing operation is same as above.Again, the aptamer RhB-F02 of the biotin labeling of 100 μ L is added per hole, is sealed in 37
DEG C, 100 rpm be incubated 2 h, after being incubated, washing operation is same as above.Then 100 μ L horseradish peroxidases are added per hole, are protected from light
37 DEG C, 100 rpm, 2 h of incubation are sealed in, after being incubated, washing operation is same as above.100 μ L TMB color developing agents are added per hole again, in
37 DEG C, be protected from light colour developing 20 min.Finally, 50 μ L terminate liquids are added per hole(The 2 M concentrated sulfuric acids), and in 10 min of reaction terminating
It is interior, using microplate reader in the light absorption value of 450 nm, measure OD450.
Meanwhile preparing to prepare the standard curve of rhodamine B.Rhodamine B standard items are diluted to 5 concentration, are followed successively by 1
Ng/mL, 4 ng/mL, 8 ng/mL, 10 ng/mL, 20 ng/mL, then carry out the measurement of ELONA methods, and operating procedure is same as above.It will
The OD450 measured carries out the drafting of standard curve, and the thick chilli sauce containing various concentration rhodamine B is calculated by this curve
In, the rate of recovery of the aptamer RhB-F02 to it.
Table 1 the result shows that:Aptamer RhB-F02 is 81.67% ~ 97.51% to the detection rate of recovery of rhodamine B.Text
Display is offered, when the rate of recovery is between 80.00% to 120.00%, then it represents that used ELONA methods may be used as the inspection of sample
It surveys.Therefore, aptamer RhB-F02 can be used for the actually detected of rhodamine B in food.
Recovery of standard addition of the 1 aptamer RhB-F02 of table in thick chilli sauce
。
Sequence table
<110>Kunming University of Science and Technology
<120>A kind of aptamer RhB-F02 and its application with rhodamine B specific binding
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 82
<212> DNA
<213>Artificial sequence (Artificial)
<400> 1
gctagacgat attcgtccat ctcccgtgca tccgagaccg tgagttggac tgacccgctt 60
ccgctgtcag actgaatatg tc 82
<210> 2
<211> 20
<212> DNA
<213>Artificial sequence (Artificial)
<400> 2
gacatattca gtctgacagc 20
<210> 3
<211> 21
<212> DNA
<213>Artificial sequence (Artificial)
<400> 3
gctagacgat attcgtccat c 21
<210> 4
<211> 20
<212> DNA
<213>Artificial sequence (Artificial)
<400> 4
gacatattca gtctgacagc 20
<210> 5
<211> 21
<212> DNA
<213>Artificial sequence (Artificial)
<400> 5
cgctgtcaga ctgaatatgt c 21
<210> 6
<211> 21
<212> DNA
<213>Artificial sequence (Artificial)
<400> 6
gctagacgat attcgtccat c 21
<210> 7
<211> 21
<212> DNA
<213>Artificial sequence (Artificial)
<400> 7
gatggacgaa tatcgtctag c 21
Claims (3)
1. a kind of aptamer RhB-F02, nucleotide sequence such as SEQ ID NO with rhodamine B specific binding:1 institute
Show.
2. the aptamer RhB-F02 according to claim 1 with rhodamine B specific binding, it is characterised in that:Two
Level structure has ring outstanding and stem, and there are tetra- stranded structures of G-, and Gibbs free energy is DG=- 10.51.
3. the aptamer RhB-F02 described in claim 1 specifically bound with rhodamine B sieve in preparing detection food
The reagent of red bright B is preparing the application detected in food in the kit of rhodamine B.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810178606.2A CN108486119B (en) | 2018-03-05 | 2018-03-05 | Aptamer RhB-F02 specifically bound with rhodamine B and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810178606.2A CN108486119B (en) | 2018-03-05 | 2018-03-05 | Aptamer RhB-F02 specifically bound with rhodamine B and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108486119A true CN108486119A (en) | 2018-09-04 |
CN108486119B CN108486119B (en) | 2020-10-27 |
Family
ID=63341608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810178606.2A Active CN108486119B (en) | 2018-03-05 | 2018-03-05 | Aptamer RhB-F02 specifically bound with rhodamine B and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108486119B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110423754A (en) * | 2019-05-06 | 2019-11-08 | 昆明理工大学 | Aptamer and utilization SELEX screening technique and application with borax specific binding |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105177010A (en) * | 2015-08-10 | 2015-12-23 | 昆明理工大学 | Nucleic acid aptamer specifically combined with Sudan Red and application of nucleic acid aptamer |
CN107505463A (en) * | 2017-07-17 | 2017-12-22 | 昆明理工大学 | With the aptamer Sf B09 of sodium formaldehyde sulfoxylate specific bond and its application |
-
2018
- 2018-03-05 CN CN201810178606.2A patent/CN108486119B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105177010A (en) * | 2015-08-10 | 2015-12-23 | 昆明理工大学 | Nucleic acid aptamer specifically combined with Sudan Red and application of nucleic acid aptamer |
CN107505463A (en) * | 2017-07-17 | 2017-12-22 | 昆明理工大学 | With the aptamer Sf B09 of sodium formaldehyde sulfoxylate specific bond and its application |
Non-Patent Citations (3)
Title |
---|
CHARLES WILSON ET AL.: "Isolation of a fluorophore-specific DNA aptamer with weak redox activity", 《CHEMISTRY & BIOLOGY》 * |
云雯等: "基于核酸适配体的生物传感技术在食品安全领域中的研究进展", 《食品工业科技》 * |
徐敦明等: "核酸适体技术在食品安全分析中的应用", 《分析化学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110423754A (en) * | 2019-05-06 | 2019-11-08 | 昆明理工大学 | Aptamer and utilization SELEX screening technique and application with borax specific binding |
Also Published As
Publication number | Publication date |
---|---|
CN108486119B (en) | 2020-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104745589B (en) | A kind of screening technique of nucleic acid aptamer of specific recognition streptomysin and application | |
EP3018212B1 (en) | Oligonucleotide aptamer specifically recognizing t-2 toxin | |
JP2008502332A5 (en) | ||
CN104745588B (en) | A kind of nucleic acid aptamer of specific recognition streptomysin and its application in streptomysin detection | |
CN108866065B (en) | ssDNA aptamer for specifically recognizing gentamicin and application thereof | |
CN107505463B (en) | With the aptamer Sf-B09 of sodium formaldehyde sulfoxylate specific bond and its application | |
CN108251429A (en) | A kind of aptamer Met-G02 and its application with acephatemet specific binding | |
CN105039346B (en) | A kind of aptamer and application with melamine specific bond | |
CN107462714B (en) | With the aptamer Sf-A09 of sodium formaldehyde sulfoxylate specific bond and its application | |
CN106929510A (en) | A kind of specific nucleic acid aptamers and application | |
CN108486119A (en) | A kind of aptamer RhB-F02 and its application with rhodamine B specific binding | |
CN105177009B (en) | A kind of aptamer and application with α-amanita hemolysin specific bond | |
CN105177011B (en) | A kind of aptamer and application with clenbuterol hydrochloride specific bond | |
CN112029771B (en) | Aptamer specifically binding to meperidine and application thereof | |
JP5835778B2 (en) | PSA-binding aptamer and PSA detection kit | |
CN105039347B (en) | A kind of aptamer and application with glyphosate specific bond | |
CN104862314B (en) | A kind of and the aptamer of α amanita hemolysin specific bonds and application | |
CN108949765B (en) | Aptamer specifically combined with nodulotoxin-R and application thereof | |
CN107505464A (en) | With the aptamer Sf E07 of sodium formaldehyde sulfoxylate specific bond and its application | |
CN113549626B (en) | Aptamer Pr-A08 specifically bound with procymidone and application thereof | |
CN105177010B (en) | A kind of aptamer and application with tonyred specific bond | |
WO2018189639A1 (en) | Escherichia coli o157:h7 aptamer and applications thereof | |
CN109517823A (en) | A kind of aptamer of clostridium difficile binary toxin A chain | |
CN104561010B (en) | Homocysteine aptamer HCy5 and preparation method thereof | |
CN110423754A (en) | Aptamer and utilization SELEX screening technique and application with borax specific binding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |